We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$8.1B
AUM Growth
+$4.9B
Cap. Flow
+$4.22B
Cap. Flow %
52.11%
Top 10 Hldgs %
26.76%
Holding
6,444
New
505
Increased
3,426
Reduced
1,637
Closed
524

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$314M
2
AAPL icon
Apple
AAPL
+$247M
3
MSFT icon
Microsoft
MSFT
+$235M
4
AMZN icon
Amazon
AMZN
+$110M
5
NVDA icon
NVIDIA
NVDA
+$99M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Financials 11.29%
3 Healthcare 10.69%
4 Consumer Discretionary 10.28%
5 Industrials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSB
4001
Mesabi Trust
MSB
$306M
$12.9K ﹤0.01%
632
+152
+32% +$3K
CUE icon
4002
Cue Biopharma
CUE
$128M
$12.9K ﹤0.01%
163
-21
-11% -$1.5K
BDTX icon
4003
Black Diamond Therapeutics
BDTX
$121M
$12.9K ﹤0.01%
4,592
-3,258
-42% -$7.64K
LNKB
4004
DELISTED
LINKBANCORP
LNKB
$12.9K ﹤0.01%
1,618
-5,494
-77% -$36.3K
MRCC
4005
DELISTED
Monroe Capital Corp
MRCC
$12.9K ﹤0.01%
+1,825
New +$12.9K
CDZI icon
4006
Cadiz
CDZI
$292M
$12.9K ﹤0.01%
4,602
-8,648
-65% -$26.1K
MYPS icon
4007
PLAYSTUDIOS Inc
MYPS
$67.3M
$12.9K ﹤0.01%
4,751
-1,044
-18% -$2.85K
DIT icon
4008
AMCON Distributing
DIT
$66.4M
$12.9K ﹤0.01%
99
-92
-48% -$11.4K
PTPI
4009
DELISTED
Petros Pharmaceuticals
PTPI
$12.9K ﹤0.01%
365
+263
+258% +$9.41K
LEV
4010
DELISTED
The Lion Electric Company
LEV
$12.8K ﹤0.01%
7,253
+634
+10% +$1.1K
NHTC icon
4011
Natural Health Trends
NHTC
$15.4M
$12.8K ﹤0.01%
2,190
-465
-18% -$2.56K
IEF icon
4012
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
$12.8K ﹤0.01%
+133
New +$12.3K
IGMS
4013
DELISTED
IGM Biosciences
IGMS
$12.8K ﹤0.01%
1,542
-1,356
-47% -$7.87K
HWBK icon
4014
Hawthorn Bancshares
HWBK
$276M
$12.8K ﹤0.01%
505
-901
-64% -$17.8K
TSQ icon
4015
Townsquare Media
TSQ
$103M
$12.8K ﹤0.01%
1,212
-54
-4% -$511
TTOO
4016
DELISTED
T2 Biosystems, Inc
TTOO
$12.8K ﹤0.01%
2,039
+2,036
+67,867% +$15.6K
CMBM
4017
DELISTED
Cambium Networks
CMBM
$12.8K ﹤0.01%
2,128
-7,026
-77% -$34.6K
EBMT icon
4018
Eagle Bancorp Montana
EBMT
$188M
$12.8K ﹤0.01%
808
-319
-28% -$4K
CYPH
4019
Cypherpunk Technologies Inc
CYPH
$70.9M
$12.8K ﹤0.01%
3,078
+412
+15% +$892
BELFA icon
4020
Bel Fuse Inc Class A
BELFA
$3.43B
$12.7K ﹤0.01%
197
+139
+240% +$7.32K
DRN icon
4021
Direxion Daily Real Estate Bull 3X ETF
DRN
$45M
$12.7K ﹤0.01%
+1,199
New +$9.41K
OCEA
4022
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
$12.7K ﹤0.01%
19,292
+6,771
+54% +$9.29K
AGM.A icon
4023
Federal Agricultural Mortgage Class A
AGM.A
$1.79B
$12.7K ﹤0.01%
81
-27
-25% -$3.41K
UTMD icon
4024
Utah Medical Products
UTMD
$230M
$12.7K ﹤0.01%
151
-1,298
-90% -$108K
ZURA icon
4025
Zura Bio
ZURA
$554M
$12.7K ﹤0.01%
2,723
+965
+55% +$4.82K

Similar funds

Tower Research Capital (TRC)'s Q4 2023 Portfolio in Review

As of Q4 2023, Tower Research Capital (TRC) held 6,444 positions worth $8.1B, up 153% from $3.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $4.22B of net new capital in Q4 2023, opening 505 new positions and adding to 3,426 existing holdings. Its largest new stake was Veralto: 28,523 shares worth $2.35M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $21.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2023 buy was Veralto: 28,523 shares worth $2.35M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $314M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $21.7M.
  • Tower Research Capital (TRC) fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2023, selling an estimated $6.02M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $8.1B portfolio in Q4 2023.
  • Tower Research Capital (TRC) opened 505 new positions and closed 524 in Q4 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 153% quarter-over-quarter to $8.1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.